12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Other News

Aeras infectious news

Aeras, a not-for-profit biotech developing TB vaccines, received a grant of up to $220 million over five years from the Bill & Melinda Gates Foundation. Aeras said the funding is based on preclinical...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >